Results 331 to 340 of about 3,617,077 (391)

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Phytotherapy in Community Pharmacy: Legal Aspects, Uses, and Interactions. [PDF]

open access: yesFarm Comunitarios
Busto Domínguez I   +5 more
europepmc   +1 more source

Adoption of international good manufacturing practices in the Nigerian pharmaceutical industry: promising results from a decade of investment. [PDF]

open access: yesJ Pharm Policy Pract
Adeyeye M   +12 more
europepmc   +1 more source

Availability, price and affordability of anticancer medicines in Jiangsu Province, China: a cross-sectional survey study. [PDF]

open access: yesFront Public Health
Yao Y   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy